Nationwide Recall of Robitussin Cough Syrup Issued Due to Contamination

Haleon, the U.S.-based unit of the U.K.-based global consumer health company, has announced a recall of Robitussin cough syrup sold nationwide. This decision is prompted by the detection of microbial contamination, which poses a potential risk of deadly infections, especially for individuals with compromised immune systems. The Food and Drug Administration (FDA) shared a notice highlighting the severity of the situation.

The use of the affected Robitussin products could potentially lead to severe or life-threatening fungal infections in individuals with weakened immune systems, according to the company. While most users may not experience serious health issues, the potential for infections requiring medical intervention cannot be ruled out.

Robitussin, commonly utilized to alleviate symptoms associated with colds, flu, hay fever, or other respiratory allergies, is the focus of this recall. The identified products, along with their corresponding lot numbers and expiration dates, are as follows:

1.  Robitussin Honey CF Max Day Adult 4oz — Lot Number: T10810 — Expiration Date: October 31, 2025
2.  Robitussin Honey CF Max Day Adult 8oz — Lot Numbers: T08730, T08731, T08732, T08733 — Expiration Date: May 31, 2025
3. Robitussin Honey CF Max Day Adult 8oz — Lot Number: T10808 — Expiration Date: September 30, 2025
4.  Robitussin Honey CF Max NT Adult 8oz — Lot Numbers: T08740, T08742 — Expiration Date: June 30, 2026

Consumers who have purchased any of these recalled products are urged to stop using them immediately and return them to the point of purchase. Additionally, individuals with health concerns or questions related to the recall are advised to contact their healthcare provider or seek medical assistance promptly.